|SERES THERAPEUTICS, INC. filed this Form 8-K on 10/16/2017|
Clinical Remission is now
recommended by FDA as the primary endpoint for UC registrational studies “We currently recommend a primary endpoint of clinical remission (responder definition based on Stool Frequency, Rectal Bleeding, and Endoscopy scores).” Clinical
Remission is based on objective endoscopy measure, not subjective as would be Clinical Response FDA Ulcerative colitis draft 2016 guidance: Clinical Trial Endpoints – Guidance for Industry Ulcerative Colitis: Clinical Trial Endpoints Guidance
© Seres Therapeutics. All Rights Reserved.